Combination chemotherapy for the treatment of invasive infections by Scedosporium prolificans

This publication has 10 references indexed in Scilit:

• In Vitro Interaction of Terbinafine with Itraconazole against Clinical Isolates of Scedosporium prolificans
  Antimicrobial Agents and Chemotherapy, 2000
• Clinical, pathologic and epidemiologic features of infection with Scedosporium prolificans: four cases and review
  Clinical Microbiology & Infection, 1999
• Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance
  Clinical Microbiology Reviews, 1999
• In Vitro Activity of Syn-2869, a Novel Triazole Agent, against Emerging and Less Common Mold Pathogens
  Antimicrobial Agents and Chemotherapy, 1999
• Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum
  Journal of Antimicrobial Chemotherapy, 1999
• Successful Medical Therapy for Deeply Invasive Facial Infection Due toPythium insidiosumin a Child
  Clinical Infectious Diseases, 1998
• In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles
  Antimicrobial Agents and Chemotherapy, 1997
• In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds
  Antimicrobial Agents and Chemotherapy, 1997
• Oral terbinafine for treatment of pulmonaryPseudallescheria boydii infection refractory to itraconazole therapy
  European Journal of Clinical Microbiology & Infectious Diseases, 1997
• Activities of amphotericin B and antifungal azoles alone and in combination against Pseudallescheria boydii
  Antimicrobial Agents and Chemotherapy, 1995